Relying on this treatment alone and avoiding or delaying conventional medical care for cancer, may have serious health consequences." Dr. Lee Wattenberg, MD was able to show that substances found in coffee – kahweol and cafestol palmitate – promote the activity of a key enzyme system, ...
Smart nanoparticles, which can respond to biological cues or be guided by them, are emerging as a promising drug delivery platform for precise cancer treatment. The field of oncology, nanotechnology, and biomedicine has witnessed rapid progress, leading to innovative developments in smart nanoparticles...
用于癌症和慢性感染的治疗的具有激动剂活性的衍生自il-2的多肽 For the treatment of cancer and chronic infections with agonist activity derived from the polypeptide il-2doi:CN103201284 ACNK·莱昂蒙松S·佩雷罗德里格斯A·B·拉赫达维拉
Treatment-naive patients with advanced PC and no obvious infections were eligible for enrolment in this study. Pathological confirmation was obtained from all the patients via either a fine-needle aspiration biopsy or a cytological examination. All the patients were scheduled to undergo chemotherapy at...
Adoption of Hybrid MRI-Linac Systems for the Treatment of Brain Tumors: A Systematic Review of the Current Literature Regarding Clinical and Technical Features. January 01, 2023 [MEDLINE Abstract] Impact of Respiratory Motion on the Skin Dose for Breast Cancer in Tomotherapy: A Study in the In...
Mark Roschewski, MD, a specialist in lymphoma at the NCI's Center for Cancer Research, stated of the therapy: "This therapy represents a tremendous development for the treatment of recurrent and treatment-resistant MCL and should be evaluated in all patients with the illness. According to Dr....
While the proportion of iCAFs remained unchanged after anti-PD-1 treatment, it is possible that their transcriptional profiles underwent changes. To explore this possibility, we conducted differential expression analysis. Interestingly, we found that Chitinase-3-Like-1 (CHI3L1) was significantly upregul...
BlueCross BlueShield Association (BCBSA), Technology Evaluation Center (TEC). Special Report: Vaccines for the treatment of malignant melanoma. TEC Assessment Program. Chicago, IL: BCBSA; May 2001:16(4). Bystryn JC, Reynolds SR. Melanoma vaccines: What we know so far. Oncology (Williston Pa...
Heterogeneity and treatment landscape of ovarian carcinoma Article 02 October 2023 Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence Article Open access 29 July 2020 Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian canc...
Development of vaccines for the treatment of cancer has posed many challenges, but results from some recent studies have confirmed the potential for clinical benefit Progress has been driven by advances in our understanding of cancer immunology and, in particular, the nature and dynamics of the tumo...